Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
Total Current Assets
Samsung Biologics Co Ltd
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Samsung Biologics Co Ltd
KRX:207940
|
Total Current Assets
₩5.6T
|
CAGR 3-Years
46%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Total Current Assets
₩11.2B
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Total Current Assets
₩348.4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Total Current Assets
₩31.3B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Total Current Assets
₩134.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
20%
|
C
|
Cellivery Therapeutics Inc
KOSDAQ:268600
|
Total Current Assets
₩29.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
See Also
What is Samsung Biologics Co Ltd's Total Current Assets?
Total Current Assets
5.6T
KRW
Based on the financial report for Mar 31, 2024, Samsung Biologics Co Ltd's Total Current Assets amounts to 5.6T KRW.
What is Samsung Biologics Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
30%
Over the last year, the Total Current Assets growth was -8%. The average annual Total Current Assets growth rates for Samsung Biologics Co Ltd have been 46% over the past three years , 30% over the past five years .